Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy

• Li Tang,
• Demin Cai,
• Mian Qin,
• Shuo Lu,
• Ming-Hao Hu,
• Shuangchen Ruan,
• Guangyi Jin,
• Zhigang Wang

Affiliations

Li Tang

†School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, P. R. China

Demin Cai

†School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, P. R. China

Mian Qin

†School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, P. R. China

Shuo Lu

†School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, P. R. China

Ming-Hao Hu

†School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, P. R. China

Shuangchen Ruan

‡Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, P. R. China

Guangyi Jin

†School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, P. R. China

Zhigang Wang

†School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, P. R. China